You are here

German firm Syntellix opens first overseas facility in Singapore

The orthopaedic implant maker projects that overall investment will reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then

From left: German Ambassador to Singapore Ulrich Sante, Economic Development Board of Singapore chairman Beh Swan Gin, Syntellix founder and CEO Utz Claassen and Lee & Lee managing partner Kwa Kim Li at the opening of Syntellix's production facility in Singapore on Tuesday.


SYNTELLIX, a German firm that pioneered the use of bioabsorbable bone implants, opened its first overseas production site in Singapore on Tuesday, amid expectations of strong growth in the medical technology industry in this region.


BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to